AZD8895

tixagevimab · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD8895, covering 2024-11-25 to 2024-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants [Phase 1]

See pricing